The cumulative amounts of grants received from the IIA and recognized by the company, as of the balance sheet date.

No definition available.

Name:	cmmb_CumulativeAmountsOfGrantsReceivedAndRecognized
Namespace Prefix:	cmmb_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Lien on bank deposit.

+ References

No definition available.

+ Details

Name:	cmmb_LienOnBankDeposit
Namespace Prefix:	cmmb_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The maximum percentage of royalties payable on the amount of the grant received (dollar linked), plus interest at annual rate based on LIBOR.

+ References

No definition available.

+ Details

Name:	cmmb_MaximumPercentageOfPaymentsOfRoyalties
Namespace Prefix:	cmmb_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Payment on commencement of agreement.

+ References

No definition available.

+ Details

Name:	cmmb_PaymentOnLongTermPurchaseCommitmentCommencementOfAgreement
Namespace Prefix:	cmmb_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The percentage of royalty payments on sale of product developed with funding received from the IIA.

+ References

No definition available.

+ Details

Name:	cmmb_PercentageOfRoyaltyPaymentsOnSaleOfProduct
Namespace Prefix:	cmmb_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

The minimum amount the entity agreed to spend under the long-term purchase commitment.

+ References

No definition available.

+ Details

Name:	us-gaap_LongTermPurchaseCommitmentAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Describes the terms of a significant arrangement with a supplier (excluding an unconditional purchase obligation) to acquire goods or services over a period of time beyond one year or the normal operating cycle, if longer, which may include identification of the goods or services to be purchased, pricing, effects on pricing of failing to reach minimum quantities required to be purchased, cancellation rights, and termination provisions.

+ References

No definition available.

+ Details

Name:	us-gaap_LongTermPurchaseCommitmentDescription
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Description of the nature and terms of commitment.

+ References

No definition available.

+ Details

Name:	us-gaap_OtherCommitmentsDescription
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_OtherCommitmentsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Investments which are not defined as or included in marketable (debt, equity, or other) securities whose use is restricted in whole or in part, generally by contractual agreements or regulatory requirements. For use in an unclassified balance sheet.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 954
-SubTopic 210
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=120413173&loc=SL6242262-115580

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 954
-SubTopic 210
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=120413209&loc=SL6242269-115581

+ Details

Name:	us-gaap_RestrictedInvestments
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.3)
-URI http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227

+ Details

Name:	us-gaap_RoyaltyExpense
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Details

Name:	srt_CurrencyAxis=currency_EUR
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=us-gaap_CapitalAdditionsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=cmmb_CapitalAdditionsOneMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=us-gaap_LeaseAgreementsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_StatementScenarioAxis=srt_ScenarioForecastMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CurrencyAxis=currency_ILS
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Commitments and Contingent Liabilities (Details) € in Thousands, ₪ in Thousands, $ in Thousands	1 Months Ended			6 Months Ended	12 Months Ended
	May 31, 2020 USD ($)	May 31, 2020 ILS (₪)	Jun. 30, 2015 EUR (€)	Nov. 30, 2021 EUR (€)	Dec. 31, 2022 USD ($)	Dec. 31, 2022 ILS (₪)	Dec. 31, 2021 USD ($)	Dec. 31, 2020 USD ($)
Other Commitments [Line Items]
Decsription of occurrence for payments							upon the occurrence of either (i) closing of a public offering of the ordinary shares of Chemomab; or (ii) a Change of Control Transaction, Chemomab shall pay the Fund a cash payment equal to one percent (1%) of the proceeds raised by Chemomab in its initial public offering, or 1% of the consideration received by Chemomab or its shareholders at the closing of a Change of Control Transaction (after deduction of amounts paid as liquidation preference to the shareholders of Chemomab on account of their investment in Chemomab , if any), but in any event not more than USD 3,000 thousand.
Maximum percentage of payments of royalties (as a percent)							100.00%
Cumulative amounts of grants received							$ 1,227
Royality expenses							2,590	$ 1,177
Bank restricted deposit							$ 55
Euro [Member]
Other Commitments [Line Items]
Payment for licensed agreement \| €			€ 1,200	€ 5,831
Payment on commencement of agreement \| €			€ 600
New Drug Application and Biological License Application [Member]
Other Commitments [Line Items]
Description of application payment for licensed product							USD 100 thousand upon submission of a New Drug Application (“NDA”), Biological License Application (“BLA”) or equivalent for each Licensed Product to the United States Food and Drug Administration (“FDA”), USD 100 thousand upon submission of similar application for each Licensed Product to an equivalent foreign regulatory agency in Europe and one hundred thousand dollars upon submission of similar application for each Licensed Product to an equivalent foreign regulatory agency in Asia. Payment in the aggregate shall not be more than USD 300 thousand per each Licensed Product, provided that for each jurisdiction, payment shall be made only once;
Royalty payments on sale of product (as a percent)							3.00%
FDA or equivalent agency marketing approval [Member]
Other Commitments [Line Items]
Description of application payment for licensed product							USD 200 thousand upon the grant of FDA or equivalent agency marketing approval in Europe and/or Asia for each Licensed Product. Payment in the aggregate shall not be more than USD 600 thousand per each Licensed Product, provided that for each jurisdiction, payment shall be made only once.
2020 Lien [Member]
Other Commitments [Line Items]
Lien on bank deposit	$ 49
2020 Lien [Member] \| Forecast [Member]
Other Commitments [Line Items]
Lien on bank deposit					$ 86
2020 Lien [Member] \| ILS [Member]
Other Commitments [Line Items]
Lien on bank deposit \| ₪		₪ 170
2020 Lien [Member] \| ILS [Member] \| Forecast [Member]
Other Commitments [Line Items]
Lien on bank deposit \| ₪						₪ 269